(Q97690433)

English

SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus

article published in 2020

In more languages

edit

Statements

instance of

scholarly article

0 references

title

SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus (English)

0 references

0 references

1 reference

1 reference

1 reference

1 reference

Michele Costanzo

1

0 references

Maria Anna Rachele De Giglio

series ordinal

2

0 references

Giovanni Nicola Roviello

series ordinal

3

0 references

language of work or name

English

0 references

publication date

16 April 2020

0 references

published in

Current Medicinal Chemistry

0 references

Identifiers

PubMed ID

32297571

0 references

(Q97690433)

SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)